| Market Cap | 39.74B | P/E | 32.88 | EPS this Y | 5.20% | Ern Qtrly Grth | - |
| Income | 929M | Forward P/E | 16.25 | EPS next Y | 21.20% | 50D Avg Chg | -1.00% |
| Sales | 17.23B | PEG | 1.62 | EPS past 5Y | 4.08% | 200D Avg Chg | -7.00% |
| Dividend | 1.00% | Price/Book | 1.55 | EPS next 5Y | 11.95% | 52W High Chg | -18.00% |
| Recommedations | 2.10 | Quick Ratio | 0.79 | Shares Outstanding | 698.88M | 52W Low Chg | 6.00% |
| Insider Own | 0.09% | ROA | 2.93% | Shares Float | 700.45M | Beta | 0.77 |
| Inst Own | 82.59% | ROE | 3.70% | Shares Shorted/Prior | 9.58M/8.45M | Price | 55.90 |
| Gross Margin | 42.50% | Profit Margin | 4.27% | Avg. Volume | 3,407,616 | Target Price | 61.95 |
| Oper. Margin | 2.00% | Earnings Date | May 1 | Volume | 3,358,282 | Change | -0.07% |
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
| Oppenheimer | Outperform | Apr 16, 24 |
| JP Morgan | Neutral | Apr 12, 24 |
| Barclays | Equal-Weight | Apr 10, 24 |
| Keybanc | Overweight | Apr 9, 24 |
| Wolfe Research | Outperform | Mar 1, 24 |
| Loop Capital | Buy | Feb 12, 24 |
| Oppenheimer | Outperform | Feb 2, 24 |
| RBC Capital | Outperform | Feb 2, 24 |
| Keybanc | Overweight | Feb 2, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| GLENN TIMOTHY P | EVP, Seed Business U.. EVP, Seed Business Unit | Nov 14 | Buy | 45.9861 | 4,000 | 183,944 | 163,121 | 11/15/23 |
| FUERER CORNEL B | SVP, Gen Counsel and.. SVP, Gen Counsel and Secretary | Nov 13 | Buy | 43.4074 | 350 | 15,193 | 108,006 | 11/15/23 |
| ANDERSON DAVID J | EVP, Chief Financial.. EVP, Chief Financial Officer | Sep 15 | Buy | 52.97 | 2,000 | 105,940 | 65,308 | 09/18/23 |
| Engel Klaus A | Director Director | Mar 15 | Sell | 52.76 | 3,000 | 158,280 | 28,742 | 03/17/22 |
| Magro Charles V. | Chief Executive Offi.. Chief Executive Officer | Feb 11 | Buy | 51.35 | 50,000 | 2,567,500 | 50,000 | 02/15/22 |
| TITUS BRIAN | See Remarks See Remarks | May 11 | Option | 32.75 | 29,937 | 980,437 | 49,184 | 05/11/21 |
| TITUS BRIAN | See Remarks See Remarks | May 11 | Sell | 49.04 | 29,937 | 1,468,110 | 19,247 | 05/11/21 |
| FRIEDMAN GREGORY R | Executive VP, CFO Executive VP, CFO | Mar 03 | Option | 32.36 | 12,157 | 393,401 | 67,872 | 03/03/21 |
| FUERER CORNEL B | SVP, Gen Counsel and.. SVP, Gen Counsel and Secretary | Feb 24 | Option | 35.95 | 41,685 | 1,498,576 | 58,758 | 02/24/21 |
| TITUS BRIAN | See Remarks See Remarks | Dec 07 | Option | 26.76 | 10,821 | 289,570 | 21,049 | 12/07/20 |
| TITUS BRIAN | See Remarks See Remarks | Dec 07 | Sell | 38.51 | 8,545 | 329,068 | 12,595 | 12/07/20 |
| GUTTERSON NEAL | SVP, Chief Technolog.. SVP, Chief Technology Officer | Dec 01 | Option | 31.27 | 39,326 | 1,229,724 | 42,381 | 12/01/20 |
| GUTTERSON NEAL | SVP, Chief Technolog.. SVP, Chief Technology Officer | Dec 01 | Sell | 36.6 | 39,326 | 1,439,332 | 22,589 | 12/01/20 |
| GLENN TIMOTHY P | EVP, Chief Commercia.. EVP, Chief Commercial Officer | Nov 12 | Option | 27.17 | 8,615 | 234,070 | 77,164 | 11/12/20 |
| FRIEDMAN GREGORY R | Executive VP, CFO Executive VP, CFO | Nov 12 | Option | 27.17 | 18,326 | 497,917 | 75,352 | 11/12/20 |